case_images: PMC4428504_01
case_images: Computing tomography scan showing multifocal abnormalities, involving both lobes of the liver. The uninvolved portions of hepatic parenchyma underwent relative hypertrophy. No calcification was visible initially. In the left liver, lesions coalesce, forming a diffuse pattern. So the target lesion was chosen in the right liver, initially measuring 138 x 146 mm, extending to the capsular margin with areas of retraction. After administration of IV contrast material, this main nodule displayed marginal enhancement during the portal phase. Inferior vena cava was compressed but remained permeable.
case_images: 13569_2014_18_Fig1_HTML.jpg
case_images: PMC4428504_01_13569_2014_18_Fig1_HTML.jpg
case_images: Fig1
case_images: CT scan assessment after 3 months demonstrated stable hepatic and pulmonary disease (Figure 1).
case_images: Chest scanner of November 2007 showing micronodular pulmonary lesions.
case_images: 13569_2014_18_Fig2_HTML.jpg
case_images: PMC4428504_01_13569_2014_18_Fig2_HTML.jpg
case_images: Fig2
case_images: Tumors criteria v. 1.0,10, tumor response consisted in a prolonged stabilization (Figures 2, 3 and 4). Importantly an ectasia of the thoracic was noted on the most recent echocardiography, this anomaly will be carefully monitored. The role of pazopanib in this phenomenon observed after 8 years of treatment remains unclear but should prompt further investigations in long term survivors under VEGFR2 inhibitors including pazopanib.
case_images: CT scanner of April 2014 showing that the appearance and size of the main lesion remained similar. The target lesion measured 126*137 mm and peripheric calcifications had appeared confirming radiological tumoral control.
case_images: 13569_2014_18_Fig3_HTML.jpg
case_images: PMC4428504_01_13569_2014_18_Fig3_HTML.jpg
case_images: Fig3
case_images: Tumors criteria v. 1.0,10, tumor response consisted in a prolonged stabilization (Figures 2, 3 and 4). Importantly an ectasia of the thoracic was noted on the most recent echocardiography, this anomaly will be carefully monitored. The role of pazopanib in this phenomenon observed after 8 years of treatment remains unclear but should prompt further investigations in long term survivors under VEGFR2 inhibitors including pazopanib.
case_images: Chest scanner of October 2014 showing stable aspect of lung micronuodules.
case_images: 13569_2014_18_Fig4_HTML.jpg
case_images: PMC4428504_01_13569_2014_18_Fig4_HTML.jpg
case_images: Fig4
case_images: Tumors criteria v. 1.0,10, tumor response consisted in a prolonged stabilization (Figures 2, 3 and 4). Importantly an ectasia of the thoracic was noted on the most recent echocardiography, this anomaly will be carefully monitored. The role of pazopanib in this phenomenon observed after 8 years of treatment remains unclear but should prompt further investigations in long term survivors under VEGFR2 inhibitors including pazopanib.